Clinical Trial Update: Opioid Antagonism in Hypogonadotropic Hypogonadism [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating opioid antagonism in hypogonadotropic hypogonadism has completed. The trial addresses low testosterone in this condition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadotropic Hypogonadism
• Low Testosterone

Snippet

Sponsor: Stephanie B. Seminara, MD | Conditions: Hypogonadotropic Hypogonadism, Low Testosterone | Phase 1 | Status: COMPLETED